Results for tag: "Congenital Adrenal Hyperplasia Drug"

Congenital Adrenal Hyperplasia (CAH) is a group of inherited disorders that affect the adrenal glands. It is caused by a deficiency in the enzymes that produce cortisol and aldosterone, hormones that regulate the body's metabolism and response to stress. Treatment for CAH typically involves hormone replacement therapy, which can be administered orally or through injections. Endocrine and Metabolic Disorders Drugs are used to treat CAH and other endocrine and metabolic disorders. These drugs are designed to restore the body's balance of hormones and to reduce the symptoms of the disorder. The Congenital Adrenal Hyperplasia Drug market is a subset of the larger Endocrine and Metabolic Disorders Drugs market. It is composed of drugs that are specifically designed to treat CAH and its associated symptoms. These drugs are used to restore the body's balance of hormones and to reduce the symptoms of the disorder. Some companies in the Congenital Adrenal Hyperplasia Drug market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more